These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 369032)

  • 21. The action of trimethoprim-sulphamethoxazole against urinary pathogens.
    Smith DD; Bell SM; Levey JM; Loy YT
    Med J Aust; 1972 Feb; 1(6):263-5. PubMed ID: 4552261
    [No Abstract]   [Full Text] [Related]  

  • 22. Susceptibility of Salmonella typhi to chloramphenicol, ampicillin and cotrimoxazole.
    Vongsthongsri U; Tharavanij S
    Southeast Asian J Trop Med Public Health; 1980 Jun; 11(2):256-61. PubMed ID: 6968979
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Development of bacterial resistance against trimethoprim-sulfamethoxazole (Eusaprim)].
    Meyer-Rohn J; Liehr W
    Fortschr Med; 1974 Jan; 92(3):121-6. PubMed ID: 4206486
    [No Abstract]   [Full Text] [Related]  

  • 24. Synergy of trimethoprim-sulfamethoxazole.
    Bushby SR
    Can Med Assoc J; 1975 Jun; 112(13 Spec No):63-6. PubMed ID: 1093654
    [No Abstract]   [Full Text] [Related]  

  • 25. Resistance to trimethoprim in Klebsiellae isolated before its introduction.
    Hamilton-Miller JM; Grey D
    J Antimicrob Chemother; 1975 Jun; 1(2):213-8. PubMed ID: 1100591
    [No Abstract]   [Full Text] [Related]  

  • 26. The role of horizontal gene transfer in the spread of trimethoprim-sulfamethoxazole resistance among uropathogenic Escherichia coli in Europe and Canada.
    Blahna MT; Zalewski CA; Reuer J; Kahlmeter G; Foxman B; Marrs CF
    J Antimicrob Chemother; 2006 Apr; 57(4):666-72. PubMed ID: 16464890
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Emergence of sulfamethoxazole-trimethoprim resistant Shigella flexneri in Northeastern Brazil.
    Tiemens KM; Shipley PL; Correia RA; Shields DS; Guerrant RL
    Arq Gastroenterol; 1985; 22(4):162-5. PubMed ID: 3915680
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Effect of the drug combination trimethoprim-sulfamethoxazole on the intestinal flora of man in short- and long-term administration].
    Knothe H
    Arzneimittelforschung; 1973 May; 23(5):704-8. PubMed ID: 4197002
    [No Abstract]   [Full Text] [Related]  

  • 29. [Antibacterial effect of sulfanilamide combination drugs].
    Metz H; Preac-Mursic V
    Med Klin; 1972 Dec; 67(49):1626-31. PubMed ID: 4566636
    [No Abstract]   [Full Text] [Related]  

  • 30. [Methods for testing bacterial resistance to active substance combinations using trimethoprim and sulfamethoxazol as an example].
    Gallien R; Schönfeld H
    Arzneimittelforschung; 1971 May; 21(5):577-83. PubMed ID: 4936787
    [No Abstract]   [Full Text] [Related]  

  • 31. [Kinetics of the bactericidal effect of ampicillin, penicillin G, carbenicillin, cephalothin, kanamycin, gentamycin, polymyxin B and sulfamethoxazole-trimethoprim on Escherichia coli].
    Stille W; Shah P
    Arzneimittelforschung; 1973 Jan; 23(1):58-60. PubMed ID: 4353376
    [No Abstract]   [Full Text] [Related]  

  • 32. Dissemination of clonal groups of uropathogenic Escherichia coli is not a significant contributor to trimethoprim and sulfamethoxazole resistance in Galway, Ireland.
    Morris D; Ni Chulain M; Cormican M
    Int J Antimicrob Agents; 2007 Jul; 30(1):97-8. PubMed ID: 17459666
    [No Abstract]   [Full Text] [Related]  

  • 33. Resistance to co-trimoxazole.
    McAllister TA
    Scand J Infect Dis Suppl; 1976; (8):29-38. PubMed ID: 1084551
    [No Abstract]   [Full Text] [Related]  

  • 34. Analysis of in vitro antibacterial activities of the combination of trimethoprim and sulfamethoxazole on clinical isolates in Japan.
    J Infect Dis; 1973 Nov; 128():Suppl:502-7 p. PubMed ID: 4585955
    [No Abstract]   [Full Text] [Related]  

  • 35. Cross-resistance and associated resistance in 2478 Escherichia coli isolates from the Pan-European ECO.SENS Project surveying the antimicrobial susceptibility of pathogens from uncomplicated urinary tract infections.
    Kahlmeter G; Menday P
    J Antimicrob Chemother; 2003 Jul; 52(1):128-31. PubMed ID: 12805266
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Co-trimoxazole susceptibility tests improved with separate trimethoprim and sulfamethoxazole disks.
    Amyes SG
    J Clin Microbiol; 1981 Apr; 13(4):613-7. PubMed ID: 7014612
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The combination sulfamethoxazole-trimethoprim in vitro].
    Linzenmeier G; Neussel H
    Zentralbl Bakteriol Orig A; 1972 Sep; 221(4):511-26. PubMed ID: 4144946
    [No Abstract]   [Full Text] [Related]  

  • 38. Trimethoprim resistance and single-agent use.
    Maskell R; Pead L
    Lancet; 1989 Sep; 2(8662):557-8. PubMed ID: 2570249
    [No Abstract]   [Full Text] [Related]  

  • 39. [Frequency of Escherichia coli resistance in Switzerland].
    Braun R; Fitzi K; Gutzwiller F; Hohl HR; van der Linde F; Gelzer J
    Schweiz Med Wochenschr; 1981 Jul; 111(27-28):1048-57. PubMed ID: 7022622
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of Pseudomonas aeruginosa by ascorbic acid-sulphamethoxazole-trimethoprim combination.
    Rawal BD; Charles BG
    Southeast Asian J Trop Med Public Health; 1972 Jun; 3(2):225-8. PubMed ID: 4628346
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.